Safety, Tolerability, and Efficacy of TAK-659 in Adults With Relapsed or Refractory Acute Myelogenous Leukemia (AML)

North Shore Long Island Jewish Medical Center, New York

Johns Hopkins Hospital, Baltimore

University of North Carolina Hospital, Chapel Hill

University of Alabama at Birmingham, Birmingham

UC Health Clinical Trials Office, Cincinnati

University of Michigan Comprehensive Cancer Center, Ann Arbor

Karmanos Cancer Center, Detroit

Henry Ford Health System, Detroit

Medical College of Wisconsin, Inc., Milwaukee

Mayo Clinic, Rochester

Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago

Oncology Specialists, S.C., Niles

Baylor University Medical Center, Dallas

Dana Farber Cancer Institute, Boston

Queen Elizabeth II Health Sciences Centre, Halifax

Princess Margaret Hospital, Toronto

Wake Forest University Baptist Medical Center, Toronto